Safety of Extending The Routine Flushing Of Implanted Port Devices From 4 Weeks To 12

Overview

About this study

The purpose of this study is to find out if extending implanted port devices (IPD) flushes to every 12 weeks is safe and if it is just as effective as every 4 week flushing.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

- Hematology/Oncology patients ≥ 18 years old with an Implanted Port Device.

- No planned clinical visits for at least 12 weeks.

- No planned need to access Implanted Port Device within next 12 weeks outside of
routine flushing. Potential reasons to access can include but are not limited to lab
draw, infusion, IV contrast.

- No planned removal of IPD within 12 weeks of registration.

- No Deep Vein Thrombosis or significant Implanted Port Device complication within ≤ 4
weeks of registration.

- Patient Implanted Port Device with documented blood return ≤ 14 days of registration.

- Ability to read and speak English.

- Able to give informed consent.

Exclusion Criteria:

- Allergy to heparin

- Vulnerable populations: pregnant women, prisoners, mentally handicapped.

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 6/7/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Mankato, Minn. Mayo Clinic principal investigator Stephan Thome, M.D.	Open for enrollment	Contact information: Danielle Mutschler R.N. (507) 594-6895 Mutschler.Danielle@mayo.edu
Albert Lea, Minn. Mayo Clinic principal investigator Mina Hanna, M.D.	Open for enrollment	Contact information: Danielle Mutschler R.N. (507) 594-6895 Mutschler.Danielle@mayo.edu

Mayo Clinic Location

Status

Contact

Mankato, Minn.

Mayo Clinic principal investigator

Stephan Thome, M.D.

Open for enrollment

Contact information:

Danielle Mutschler R.N.

(507) 594-6895

Mutschler.Danielle@mayo.edu

Albert Lea, Minn.

Mayo Clinic principal investigator

Mina Hanna, M.D.

Open for enrollment

Contact information:

Danielle Mutschler R.N.

(507) 594-6895

Mutschler.Danielle@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials